# US 2013/0276779 A1 · Method of forming an aerosol for inhalation delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0276779 A1
- Document ID: US20130276779A1
- Status: Published application
- Kind: A1
- Application number: 13/851,577
- Filed: 2013-03-27
- Published: 2013-10-24
- Earliest claimed: 2001-06-05
- Assignees: Alexza Pharmaceuticals, Inc.
- Applicants: Alexza Pharmaceuticals, Inc.
- Inventors: Ron L. Hale; Craig C. Hodges; Peter M. Lloyd; Daniel Mufson; Daniel D. Rogers; Soonho Song; Martin J. Wensley; Daniel J. Myers; Jeffrey A. McKinney; Reynaldo J. Quintana; Joshua D. Rabinowitz
- Web page: https://patentgrep.com/patent/US20130276779A1

## CPC

- A61M 11/044: {with electrodes immersed in the liquid}
- A61K 9/007: {Pulmonary tract; Aromatherapy}
- A61K 9/0073: {Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; (nasal sprays A61K9/0043; inhalation of vapours of volatile or heated drugs, e.g. essential oils or nicotine, A61K9/007; devices A61M)}
- A61K 31/235: having an aromatic ring attached to a carboxyl group
- A61K 31/4468: having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
- A61K 31/485: Morphinan derivatives, e.g. morphine, codeine
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61M 11/001: {Particle size control}
- A61M 11/02: operated by air {or other gas} pressure applied to the liquid {or other product} to be sprayed or atomised {(sprayers for horticulture A01G, A01H; killing insects A01M; air humidifying by nozzles F24F6/14, F24F6/18; cooling by spraying F28B, F28C)}
- A61M 15/00: Inhalators {(drug delivery in endotracheal tubes A61M16/04)}
- A61M 15/0028: {using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up}
- A61M 16/109: {the humidifying liquid or the beneficial agent}
- A61P 23/00: Anaesthetics
- B05B 7/1686: {involving vaporisation of the material to be sprayed or of an atomising-fluid-generating product}
- B05B 17/04: operating with special methods
- A61M 2016/0039: {in the inspiratory circuit}
- A61M 2205/3606: cooled
- A61M 2205/3653: by Joule effect, i.e. electric resistance
- A61M 2205/368: by electromagnetic radiation, e.g. IR waves
- A61M 2205/50: with microprocessors or computers
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- B05B: SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES (spray-mixers with nozzles B01F25/72; processes for applying liquids or other fluent materials to surfaces by spraying B05D)

## Abstract

The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. The method involves: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10μ thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another aspect, a method of forming an aerosol for use in inhalation therapy is provided, wherein the method comprises: (a) heating a substrate coated with a composition comprising a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.1 mg; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy

## Claims

### Claim 1

A method of forming an aerosol for use in inhalation therapy comprising:
(a) heating a substrate coated with a composition comprising a drug, thereby forming a vapor;
(b) establishing an airflow over the surface of the coated composition during said heating; and
(c) allowing the vapors to cool in the air flow thereby forming an aerosol comprising the drug, wherein a dose of the drug is vaporized in less than 1 second.

### Claim 2 (depends on 1)

The method according to claim 1, wherein a dose of the drug is vaporized in less than 500 milliseconds.

### Claim 3 (depends on 2)

The method according to claim 2, wherein a dose of the drug is vaporized in less than 100 milliseconds.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the formed aerosol is greater than 80 percent by weight of the drug.

### Claim 5 (depends on 3)

The method according to claim 3, wherein the formed aerosol contains less than 5 percent by weight of drug decomposition products.

### Claim 6 (depends on 3)

The method according to claim 3, wherein the formed aerosol is stable over 1 second.

### Claim 7 (depends on 3)

The method according to claim 3, wherein the formed aerosol has an MMAD in the 10 nm to 100 nm range.

### Claim 8 (depends on 3)

The method according to claim 3, wherein the formed aerosol has an MMAD in the 1 μm to 3 μm range.

### Claim 9 (depends on 3)

The method according to claim 3, wherein the geometric standard deviation of the form aerosol is other than 1.

### Claim 10 (depends on 3)

The method according to claim 3, wherein the film is less than 10 μm thick.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the film is less than 5 μm thick.

### Claim 12 (depends on 10)

The method according to claim 10, wherein the film is between 10 nm and 5 μm thick.

### Claim 13 (depends on 10)

The method according to claim 10, wherein the film is less than 3 μm thick.

### Claim 14 (depends on 12)

The method according to claim 12, wherein the film is between 10 nm and 3 μm thick.

### Claim 15

An apparatus, comprising:
a housing defining an airway extending between an inlet of the housing and an outlet of the housing, a first portion of the airway having a first cross-sectional area, a second portion of the airway having a second cross-sectional area less than the first cross-sectional area, the second portion of the airway; and
a substrate, at least a portion of the substrate having a surface in communication with the second portion of the airway, the portion of the substrate configured to be heated by a heater system such that a composition comprising a drug coated on the surface of the substrate is engaged by air passing through the airway upon inhalation by a patient, the heater system configured to heat the composition to a vaporization temperature to begin vaporization of the composition, the second portion of the airway configured to increase a speed of the air passing over the surface of the composition to remove vapors resulting from vaporization of the composition from the heated portion of the substrate, the second portion of the airway configured to cool the removed vapors below the vaporization temperature without significant decomposition of the vaporized composition.
